51³Ô¹ÏÍø

 Published: 13 Jun 2024 | Last Updated: 13 Jun 2024 15:42:20

New research from the 51³Ô¹ÏÍø (RVC) has revealed a fundamental difference between how the cells which line blood vessels (endothelial cells), react in horses compared to humans. Regulating the factors that influence endothelial cell function is sometimes used to treat diseases such as cancer in humans, so the findings pave the way for further research in both horses and humans.

Endothelial cells are responsible for the formation of new blood vessels, such as after exercise or injury. This process of forming new blood vessels is called angiogenesis. Little is known about angiogenesis in horses despite the important part it plays in many equine diseases and recovery from injury. There is also interest in the use of the horse as a large animal model for human diseases. This research was therefore conducted to improve understanding of endothelial cell function in horses.

Conducting the first-ever study to optimise methods for the isolation, growth and purification of equine endothelial cells, the RVC research team studied equine endothelial cells in vitro (in a dish). They examined factors related to the equine cells’ ability to form new blood vessels. Specific chemicals in the body stimulate endothelial cells to start the process of angiogenesis. The most studied growth factor responsible for this process in human cells is Vascular Endothelial Growth Factor A (VEGF-A), making it a focus of this research.

The findings revealed there was a difference in the function between equine and human endothelial cells. They found that VEGF-A had far less of an effect on the cells of horses than those of humans. Instead, equine endothelial cells respond much more strongly to a different growth factor known as Fibroblast Growth Factor Two (FGF2).

This difference in function between equine and human cells has never been identified before and is of great interest as to why horse cells are affected differently. Regulating VEGF-A is sometimes used as a treatment for cancer in humans, so given that equine endothelial cells do not respond to VEGF-A in the same way as human cells could be a useful trait to investigate. Further research is therefore needed to build on these outcomes and shed light on how this research can be of the greatest benefit when developing treatments for disease in horses and humans.

The RVC research team comprised Dr Elizabeth Finding, a vet and Equine Internal Medicine Specialist and Lecturer in Basic Sciences; Dr Ashton Faulkner, Lecturer in Biomedical Sciences; Miss Lilly Nash, PhD student; and Professor Caroline Wheeler-Jones, Professor of Vascular Cell Biology. Miss Misha Lee, an Undergraduate BSc student at the RVC, also contributed to the project, providing a real-world research opportunity at the leading institution.

Dr Elizabeth Finding, Lecturer in Basic Sciences and lead author of the paper, said:

“Endothelial cells are crucial to all body systems and the fact that we have known so little about them in the horse up to this stage has limited our ability to study many aspects of equine health and disease.

“Our methods can now be used by all researchers interested in the topic to further their work. I am excited by the possibility that the differences we have found between equine and human endothelial cells may be useful for studying human diseases.”

This research was funded by the Horserace Betting Levy Board.

Notes to Editors

Reference

Finding, E.J.T.; Faulkner, A.; Nash, L.; Wheeler-Jones, C.P.D. Equine Endothelial Cells Show Pro-Angiogenic Behaviours in Response to Fibroblast Growth Factor 2 but Not Vascular Endothelial Growth Factor A. Int. J. Mol. Sci. 2024, 25, 6017.

The full paper is available here:

For media enquiries, please contact:

• Jasmin De Vivo at jasmin.devivo@plmr.co.uk or rvc@plmr.co.uk 
• Press Line: 0800 368 9520

About the RVC

• The 51³Ô¹ÏÍø (RVC) is the UK's largest and longest established independent veterinary school and is a Member Institution of the University of London.
• It is one of the few veterinary schools in the world that hold accreditations from the RCVS in the UK (with reciprocal recognition from the AVBC for Australasia, the VCI for Ireland and the SAVC for South Africa), the EAEVE in the EU, and the AVMA in the USA and Canada.
• The RVC is ranked as the top veterinary school in the world in the QS World University Rankings by subject, 2024.
• The RVC offers undergraduate and postgraduate programmes in veterinary medicine, veterinary nursing and biological sciences.
• The RVC is a research-led institution, with 88% of its research rated as internationally excellent or world class in the Research Excellence Framework 2021.
• The RVC provides animal owners and the veterinary profession with access to expert veterinary care and advice through its teaching hospitals and first opinion practices in London and Hertfordshire.